Recursion Pharmaceuticals to update on FDA trial design for REC-4881 for FAP in the second half of 2026. Analysts expect potential upside from rare diseases.

Christopher Gibson, Co-Founder and CEO, announced, "beginning January 1, the amazing Najat Khan is going to take over the role of CEO, President and Director of Recursion." Gibson will transition to ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The maker of Claude wants AI labs, including itself, to prepare for a coordinated slowdown if models begin building their own ...

Anthropic says recursive self-improvement is their chosen path for AI advancing AI. I explain the ins and outs. An AI Insider ...

Statistics are the skeleton of your business, but narratives are its soul. Algorithms are now sophisticated enough to look ...

Anthropic disables Fable 5 & Mythos 5 access to all after the U.S. issues a directive to prevent foreign nationals from ...

The US government has ordered Anthropic to restrict access to Fable 5 and Mythos 5 after concerns over AI jailbreaking and ...

In The Lancet in 1971, Julian Tudor Hart gave medicine one of its most important insights: the availability of medical care tends to vary inversely with need—the inverse care law.1 Half a century ...

Sakana AI has opened a Recursive Self-Improvement Lab to test whether AI systems can help redesign and optimize future AI systems, a bet aimed at reducing frontier AI’s dependence on brute-force ...

Anthropic believes the future of AI may involve AI itself. In a new report, the company outlines how increasingly capable ...

Yuandong Tian, who spent more than a decade as a research scientist director inside Meta’s Fundamental AI Research lab, has ...